Error! You must javascript enabled to use this form. Please enable Javascript in your browser. NASDAQ: YS Investor Notice: Investigation over Potential Wrongdoing at YS Biopharma Co., Ltd. Certain directors of YS Biopharma Co., Ltd. are under investigation over potential breaches of fiduciary duties. View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send